Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated

V Macias1, R Gonzalez Celador, C Marti-Macia

  • 1Servicio de Oncología Radioterápica, Complejo Asistencial Universitario de Salamanca (CAUSA), Paseo de San Vicente 58-182, 37007, Salamanca, Spain. victormaciash@gmail.com

Abstract

Related Concept Videos